Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

235.74
-26.4200-10.08%
Post-market: 233.72-2.0200-0.86%19:19 EDT
Volume:1.88M
Turnover:458.00M
Market Cap:30.52B
PE:-108.19
High:259.16
Open:257.14
Low:235.57
Close:262.16
Loading ...
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Aug 22, 2024

Correspondence

Form CORRESP - Correspondence
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2024

Major Issues Report

Form 8-K - Current report
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 15, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]